US Bancorp’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
Other funds holding BBC
MCP
DWS
FDCDDQ
US Bancorp's BBC Position: Q3 2025 in Review
US Bancorp sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q3 2025, closing a stake of 1,000 shares — an estimated $19.3K sold.
US Bancorp first reported a position in BBC in Q4 2019 and held it in 23 quarters. The position peaked at $51K in Q1 2021. 12 funds tracked by Wall St. Rank hold BBC as of Q3 2025.
- US Bancorp reported no remaining Virtus Biotech Clinical Trials ETF position as of Q3 2025 after selling out during the quarter.
- US Bancorp sold 1,000 Virtus Biotech Clinical Trials ETF shares in Q3 2025, an estimated $19.3K.
- US Bancorp first reported a position in Virtus Biotech Clinical Trials ETF in Q4 2019 and held it in 23 quarters.
- US Bancorp's Virtus Biotech Clinical Trials ETF position peaked at $51K in Q1 2021.
- 12 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2025.
Based on US Bancorp's 13F filing for Q3 2025, filed 12 Nov 2025.